| FCVAX | VSIIX | FCVAX / VSIIX | |
| Total Expense Ratio | 1.20 | 0.06 | 2,000% |
| Annual Report Gross Expense Ratio | 1.20 | 0.06 | 2,000% |
| Fund Existence | 21 years | 26 years | - |
| Gain YTD | -3.458 | 2.289 | -151% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.42B | 58.3B | 8% |
| Annual Yield % from dividends | 0.63 | 2.03 | 31% |
| Returns for 1 year | -7.45 | -1.91 | 389% |
| Returns for 3 years | 8.73 | 24.39 | 36% |
| Returns for 5 years | 28.60 | 56.05 | 51% |
| Returns for 10 years | 11.69 | 104.71 | 11% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PCGG | 11.76 | 0.05 | +0.46% |
| Polen Capital Global Growth ETF | |||
| IWP | 134.74 | 0.52 | +0.39% |
| iShares Russell Mid-Cap Growth ETF | |||
| FDAT | 21.86 | 0.02 | +0.11% |
| Tactical Advantage ETF | |||
| TDEC | 23.58 | N/A | N/A |
| FT Vest Emerging Mkts Buffr ETF - Dec | |||
| BBEM | 63.95 | -0.26 | -0.41% |
| JPMorgan BetaBuilders Emerging Mkt EqETF | |||